AAAAAA

   
Results: 1-25 | 26-50 | 51-62
Results: 1-25/62

Authors: ZIKOS P VANLINT MT LAMPARELLI T GUALANDI F OCCHINI D MORDINI N BERISSO C BREGANTE S BACIGALUPO A
Citation: P. Zikos et al., A RANDOMIZED TRIAL OF HIGH-DOSE POLYVALENT INTRAVENOUS IMMUNOGLOBULIN(HDIGG) VS. CYTOMEGALOVIRUS (CMV) HYPERIMMUNE IGG IN ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTS (HSCT), Haematologica, 83(2), 1998, pp. 132-137

Authors: ZIKOS P VANLINT MT LAMPARELLI T GUALANDI F OCCHINI D BREGANTE S BERISSO G MORDINI N INCAGLIATO M FUGAZZA G SESSAREGO M BACIGALUPO A
Citation: P. Zikos et al., ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR PATIENTS WITH HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA - FAVORABLE IMPACT OF CHRONIC GRAFT-VERSUS-HOST DISEASE ON SURVIVAL AND RELAPSE, Haematologica, 83(10), 1998, pp. 896-903

Authors: CARELLA AM LERMA E DEJANA A CORSETTI MT CELESTI L BRUNI R BENVENUTO F FIGARI O PARODI C CARLIER P FLORIO G LERCARI G VALBONESI M CASARINO L DESTEFANO F GENIRAM A VENTURINO M TEDESCHI L PALMIERI G PIAGGIO G PODESTA M FRASSONI F VANLINT MT MARMONT AM BACIGALUPO A
Citation: Am. Carella et al., ENGRAFTMENT OF HLA-MATCHED SIBLING HEMATOPOIETIC STEM-CELLS AFTER IMMUNOSUPPRESSIVE CONDITIONING REGIMEN IN PATIENTS WITH HEMATOLOGIC NEOPLASIAS, Haematologica, 83(10), 1998, pp. 904-909

Authors: BACIGALUPO A BROCCIA G CORDA G ARCESE W DIBONA E CAROTENUTO M GALLAMINI A LOCATELLI F MORI P SARACCO P TODESCHINI G COSER P IACOPINO P VANLINT MT
Citation: A. Bacigalupo et al., LONG-TERM ADMINISTRATION OF G-CSF DOES NOT INCREASE AT 5 YEARS THE RISK OF CYTOGENETIC ABNORMALITIES IN PATIENTS WITH SEVERE APLASTIC-ANEMIA, Experimental hematology, 26(8), 1998, pp. 235-235

Authors: MARINA P PIAGGIO G FRASSONI F PITTO A ZIKOS P SESSAREGO M ABATE M VANLINT MT BERISSO G BACIGALUPO A
Citation: P. Marina et al., THE ASSESSMENT OF THE HEMATOPOIETIC RESERVOIR AFTER IMMUNOSUPPRESSIVETHERAPY (IS) OR BONE-MARROW TRANSPLANTATION (BMT) IN SEVERE APLASTIC-ANEMIA, Experimental hematology, 26(8), 1998, pp. 415-415

Authors: BACIGALUPO A ZIKOS P VANLINT MT VALBONESI M LAMPARELLI T GUALANDI F OCCHINI D MORDINI N BREGANTE S BERISSO G VITALE V SESSAREGO M MARMONT AM
Citation: A. Bacigalupo et al., ALLOGENEIC BONE-MARROW OR PERIPHERAL-BLOOD CELL TRANSPLANTS IN ADULTSWITH HEMATOLOGIC MALIGNANCIES - A SINGLE-CENTER EXPERIENCE, Experimental hematology, 26(5), 1998, pp. 409-414

Authors: MARMONT AM VANLINT MT OCCHINI D LAMPARELLI T BACIGALUPO A
Citation: Am. Marmont et al., FAILURE OF AUTOLOGOUS STEM-CELL TRANSPLANTATION IN REFRACTORY THROMBOCYTOPENIC PURPURA, Bone marrow transplantation, 22(8), 1998, pp. 827-828

Authors: MORETTI S ZIKOS P VANLINT MT TEDONE E OCCHINI D GUALANDI F LAMPARELLI T MORDINI N BERISSO G BREGANTE S BRUNO B BACIGALUPO A
Citation: S. Moretti et al., FOSCARNET VS GANCICLOVIR FOR CYTOMEGALOVIRUS (CMV) ANTIGENEMIA AFTER ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION (HSCT) - A RANDOMIZED STUDY, Bone marrow transplantation, 22(2), 1998, pp. 175-180

Authors: MACHETTI M FEASI M MORDINI N VANLINT MT BACIGALUPO A LATGE JP SARFATI J VISCOLI C
Citation: M. Machetti et al., COMPARISON OF AN ENZYME-IMMUNOASSAY AND A LATEX AGGLUTINATION SYSTEM FOR THE DIAGNOSIS OF INVASIVE ASPERGILLOSIS IN BONE-MARROW TRANSPLANT RECIPIENTS, Bone marrow transplantation, 21(9), 1998, pp. 917-921

Authors: COHEN A ROVELLI R ZECCA S VANLINT MT PARODI L GRASSO L UDERZO C
Citation: A. Cohen et al., ENDOCRINE LATE EFFECTS IN CHILDREN WHO UNDERWENT BONE-MARROW TRANSPLANTATION - REVIEW, Bone marrow transplantation, 21, 1998, pp. 64-67

Authors: BOSI A BACCI S LASZLO D LOCATELLI F MESSORI A VANLINT MT DIBARTOLOMEO P AMICI A
Citation: A. Bosi et al., COST-EFFECTIVENESS OF 2ND ALLOGENEIC BONE-MARROW TRANSPLANTATION (2BMT) IN PATIENTS WITH ACUTE-LEUKEMIA (AL), Bone marrow transplantation, 21, 1998, pp. 14-14

Authors: ZIKOS P VANLINT MT FRASSONI F LAMPARELLI T GUALANDI F OCCHINI D MORDINI N BERISSO G BREGANTE S BACIGALUPO A
Citation: P. Zikos et al., LOW TRANSPLANT MORTALITY IN ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) FOR ACUTE MYELOID-LEUKEMIA - A RANDOMIZED STUDY OF LOW-DOSE CYCLOSPORINE VS LOW-DOSE CYCLOSPORINE AND LOW-DOSE METHOTREXATE, Bone marrow transplantation, 21, 1998, pp. 38-38

Authors: ZIKOS PM VANLINT MT LAMPARELLI T GUALANDI F OCCHINI D BREGANTE S BERISSO G MORDINI N INCAGLIATO M FUGAZZA G SESSAREGO M VITALE V BARRA S CORVO R BACIGALUPO A
Citation: Pm. Zikos et al., ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION (HSCT) FOR PATIENTS WITH HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - FAVORABLE IMPACTOF CHRONIC GRAFT-VERSUS-HOST DISEASE (CGVHD) ON SURVIVAL AND RELAPSE, Bone marrow transplantation, 21, 1998, pp. 39-39

Authors: BACIGALUPO A ZIKOS P VANLINT MT VALBONESI M LAMPARELLI T GUALANDI F OCCHINI D MORDINI N BREGANTE S BERISSO G VITALE V SESSAREGO M MARMONT AM
Citation: A. Bacigalupo et al., ALLOGENEIC BONE-MARROW OR PERIPHERAL-BLOOD CELL TRANSPLANTS IN ADULTSWITH HEMATOLOGIC MALIGNANCIES - A SINGLE-CENTER EXPERIENCE, Bone marrow transplantation, 21, 1998, pp. 40-40

Authors: BACIGALUPO A VANLINT MT LAMPARELLI T GUALANDI F OCCHINI D MORDINI N BERISSO G BREGANTE S LOMBARDI A ZIKOS P
Citation: A. Bacigalupo et al., UNMANIPULATED TRANSPLANTS FROM 1-2-ANTIGEN MISMATCHED FAMILY DONORS, Bone marrow transplantation, 21, 1998, pp. 121-121

Authors: BACIGALUPO A BRAND R SOCIE G PASSY J LOCASCIULLI A VANLINT MT TICHELLI A MCCANN S MARSH J",LJUNDGMAN,"HOWS J MARIN P SCHREZENMEIER H
Citation: A. Bacigalupo et al., BONE-MARROW TRANSPLANTATION (BMT) OR IMMUNOSUPPRESSIVE THERAPY (IS) FOR PATIENTS WITH SEVERE APLASTIC-ANEMIA (SAA) - A REPORT OF THE EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTS (EBMT) SAA WORKING PARTY, Bone marrow transplantation, 21, 1998, pp. 177-177

Authors: BERISSO GA VANLINT MT OCCHINI D GUALANDI F BACIGALUPO A MARMONT AM
Citation: Ga. Berisso et al., ADOPTIVE DEVELOPMENT OF DIFFERENT ANTITHYROID AUTOANTIBODIES FOLLOWING ALLOGENEIC BLOOD AND MARROW TRANSPLANTATION, Bone marrow transplantation, 21, 1998, pp. 192-192

Authors: BACIGALUPO A VANLINT MT LAMPARELLI T GUALANDI F OCCHINI D MORDINI N BERISSO G BREGANTE S LOMBARDI A ZIKOS P
Citation: A. Bacigalupo et al., THIOTEPA CYCLOPHOSPHAMIDE (THIO-CY) AS CONDITIONING REGIMEN FOR ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTS (HSCT) - REDUCING THE DOSE FOR PATIENTS AGED 45 TO 60 YEARS, Bone marrow transplantation, 21, 1998, pp. 357-357

Authors: KLIMOVITCH A KRUTETSKAYA I VANLINT MT SAMOILOVICH M AFANASIEV B PODOLTSEVA E KLIMOVITCH V
Citation: A. Klimovitch et al., SERUM LEVELS OF THE IGG-SUBCLASSES AND TOTAL IGE IN EARLY POSTTRANSPLANTATION PERIOD IN ALLO-BMT, Bone marrow transplantation, 21, 1998, pp. 393-393

Authors: ZIKOS P VANLINT MT LAMPARELLI T GUALANDI F OCCHINI D MORDINI N BERISSO G BREGANTE S BACIGALUPO A
Citation: P. Zikos et al., A RANDOMIZED TRIAL OF HIGH-DOSE POLYVALENT INTRAVENOUS IMMUNOGLOBULIN(HDIGG) VS. CYTOMEGALOVIRUS (CMV) HYPERIMMUNE IGG IN ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTS (HSCT), Bone marrow transplantation, 21, 1998, pp. 490-490

Authors: COHEN A ROVELLI A UDERZO C PARODI L ARRIGO C VANLINT MT BERISSO G GRASSO L BACIGALUPO A
Citation: A. Cohen et al., THYROID ABNORMALITIES AFTER BMT FOR HEMATOLOGICAL DISORDERS, Bone marrow transplantation, 21, 1998, pp. 568-568

Authors: COHEN A ROVELLI A UDERZO C VANLINT MT SOCIE G GAIERO A BAKKER B CAHN JY DOPFER R ESPEROU H LEIPER A VOSSEN JM KOLB HJ
Citation: A. Cohen et al., FINAL RESULTS FROM THE STUDY OF THE WORKING PARTY FOR LATE EFFECTS ONFINAL HEIGHT OF PATIENTS WHO UNDERWENT BMT DURING CHILDHOOD, Bone marrow transplantation, 21, 1998, pp. 569-569

Authors: VANLINT MT UDERZO C LOCASCIULLI A MAJOLINO I SCIME R LOCATELLI F GIORGIANI G ARCESE W IORI AP FALDA M LOCATELLI F BOSI A MINIERO R ALESSANDRINO P DINI G ROTOLI B BACIGALUPO A
Citation: Mt. Vanlint et al., EARLY TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE WITH HIGH-DOSE OR LOW-DOSE 6-METHYLPREDNISOLONE - A MULTICENTER RANDOMIZED TRIAL FROM THE ITALIAN GROUP FOR BONE-MARROW TRANSPLANTATION, Blood, 92(7), 1998, pp. 2288-2293

Authors: ZIKOS P VANLINT MT FRASSONI F LAMPARELLI T GUALANDI F OCCHINI D MORDINI N BERISSO G BREGANTE S DESTEFANO F SORACCO M VITALE V BACIGALUPO A
Citation: P. Zikos et al., LOW TRANSPLANT MORTALITY IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOID-LEUKEMIA - A RANDOMIZED STUDY OF LOW-DOSE CYCLOSPORINEVERSUS LOW-DOSE CYCLOSPORINE AND LOW-DOSE METHOTREXATE, Blood, 91(9), 1998, pp. 3503-3508

Authors: PODESTA M PIAGGIO G FRASSONI F PITTO A ZIKOS P SESSAREGO M ABATE M VANLINT MT BERISSO G BACIGALUPO A
Citation: M. Podesta et al., THE ASSESSMENT OF THE HEMATOPOIETIC RESERVOIR AFTER IMMUNOSUPPRESSIVETHERAPY OR BONE-MARROW TRANSPLANTATION IN SEVERE APLASTIC-ANEMIA, Blood, 91(6), 1998, pp. 1959-1965
Risultati: 1-25 | 26-50 | 51-62